The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: A case-control study within the prospective EPIC cohort

  1. Grote, V.A.
  2. Nieters, A.
  3. Kaaks, R.
  4. Tjnøneland, A.
  5. Roswall, N.
  6. Overvad, K.
  7. Skjelbo Nielsen, M.R.
  8. Clavel-Chapelon, F.
  9. Boutron-Ruault, M.C.
  10. Racine, A.
  11. Teucher, B.
  12. Lukanova, A.
  13. Boeing, H.
  14. Drogan, D.
  15. Trichopoulou, A.
  16. Trichopoulos, D.
  17. Lagiou, P.
  18. Palli, D.
  19. Sieri, S.
  20. Tumino, R.
  21. Vineis, P.
  22. Mattiello, A.
  23. Suaŕez, M.V.A.
  24. Duell, E.J.
  25. Sańchez, M.J.
  26. Dorronsoro, M.
  27. Castanõ, J.M.H.
  28. Barricarte, A.
  29. Jeurnink, S.M.
  30. Peeters, P.H.M.
  31. Sund, M.
  32. Ye, W.
  33. Regner, S.
  34. Lindkvist, B.
  35. Khaw, K.-T.
  36. Wareham, N.
  37. Allen, N.E.
  38. Crowe, F.L.
  39. Fedirko, V.
  40. Jenab, M.
  41. Romaguera, D.
  42. Siddiq, A.
  43. Bueno-de-Mesquita, H.B.
  44. Rohrmann, S.
  45. Erakutsi egile guztiak +
Aldizkaria:
Cancer Epidemiology Biomarkers and Prevention

ISSN: 1055-9965

Argitalpen urtea: 2012

Alea: 21

Zenbakia: 4

Orrialdeak: 619-628

Mota: Artikulua

DOI: 10.1158/1055-9965.EPI-11-1139 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus